GAMIDA CELL LTD

YTD

ALL

Why Robinhood?

You can watch GMDAQ and buy or sell other stocks, ETFs, and their options commission-free!

About GMDAQ

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies.

CEO

Joe Wiley, PhD, MBA

CEOJoe Wiley, PhD, MBA

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1998

Founded1998

Employees

—

Employees—

GMDAQ Key Statistics

Market cap

2.62M

Market cap2.62M

Price-Earnings ratio

-0.03

Price-Earnings ratio-0.03

Dividend yield

—

Dividend yield—

Average volume

348.70K

Average volume348.70K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$2.51

52 Week high$2.51

52 Week low

$0.008

52 Week low$0.008

People also own

Based on the portfolios of people who own GMDAQ. This list is generated using Robinhood data, and it’s not a recommendation.